Shares of Lilium (NASDAQ:LILM – Get Rating) have earned a consensus rating of "Hold" from the seven brokerages that are currently covering the company, Marketbeat.com reports. Five investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 12-month price target among brokers that have issued a report on the stock in the last year is $10.77.
Several analysts have commented on LILM shares. Raymond James started coverage on Lilium in a report on Wednesday, July 27th. They issued a "market perform" rating for the company. Piper Sandler lowered their price target on Lilium from $15.00 to $10.00 and set an "overweight" rating for the company in a report on Tuesday, August 30th.
Get
Lilium alerts:
Lilium Trading Down 0.4 %
Lilium stock opened at $2.23 on Friday. The stock has a 50-day moving average price of $2.59 and a 200 day moving average price of $2.98. Lilium has a 52 week low of $2.05 and a 52 week high of $11.66.
Hedge Funds Weigh In On Lilium
Several hedge funds and other institutional investors have recently bought and sold shares of LILM. Resources Investment Advisors LLC. acquired a new position in Lilium during the 2nd quarter worth approximately $26,000. Evoke Wealth LLC lifted its position in Lilium by 86.1% during the 1st quarter. Evoke Wealth LLC now owns 9,761 shares of the company's stock worth $39,000 after acquiring an additional 4,516 shares in the last quarter. Manchester Capital Management LLC acquired a new position in Lilium during the 1st quarter worth approximately $54,000. LPL Financial LLC acquired a new position in Lilium during the 2nd quarter worth approximately $64,000. Finally, UBS Group AG lifted its position in Lilium by 250.5% during the 1st quarter. UBS Group AG now owns 19,556 shares of the company's stock worth $78,000 after acquiring an additional 13,977 shares in the last quarter. 12.19% of the stock is owned by institutional investors and hedge funds.
Lilium Company Profile
(Get Rating)
Lilium N.V., a transportation company, engages in the research and development of electric vertical takeoff and landing aircrafts for use in high-speed air transport system for people and goods. Lilium N.V. was incorporated in 2015 and is headquartered in Wessling, Germany.
Featured Articles
- Get a free copy of the StockNews.com research report on Lilium (LILM)
- No One Told These 3 Stocks It's a Down Week
- Is There a Cure for What is Ailing Teladoc Stock?
- Why Medical Products Maker Repligen May Be A Potential Buy
- At 10%, Is Arbor Realty Trust Dividend Worth It?
- Investors Should Tune Into RF Industries
Receive News & Ratings for Lilium Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lilium and related companies with MarketBeat.com's FREE daily email newsletter.
Shares of Lilium (NASDAQ:LILM – Get Rating) have earned a consensus rating of "Hold" from the seven brokerages that are currently covering the company, Marketbeat.com reports. Five investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 12-month price target among brokers that have issued a report on the stock in the last year is $10.77.
據Marketbeat.com報道，百合(納斯達克代碼：LILM-GET Rating)的股票被目前報道該公司的七家券商一致評為持有。五名投資分析師對該股的評級為持有，兩名分析師對該公司的評級為買入。在去年發佈了該股報告的經紀商中，12個月目標價的平均水平為10.77美元。
Several analysts have commented on LILM shares. Raymond James started coverage on Lilium in a report on Wednesday, July 27th. They issued a "market perform" rating for the company. Piper Sandler lowered their price target on Lilium from $15.00 to $10.00 and set an "overweight" rating for the company in a report on Tuesday, August 30th.
幾位分析師對LILM的股票發表了評論。雷蒙德·詹姆斯在7月27日星期三的一份報告中開始了對Lilium的報道。他們對該公司進行了“市場表現”評級。派珀·桑德勒在8月30日(週二)的一份報告中將他們對Lilium的目標價從15.00美元下調至10.00美元，併為該公司設定了“增持”評級。
Get
Lilium
alerts:
Lilium Trading Down 0.4 %
Lilium stock opened at $2.23 on Friday. The stock has a 50-day moving average price of $2.59 and a 200 day moving average price of $2.98. Lilium has a 52 week low of $2.05 and a 52 week high of $11.66.
上週五，Lilium的股價開盤報2.23美元。該股的50日移動均線價格為2.59美元，200日移動均線價格為2.98美元。Lilium的52周低點為2.05美元，52周高位為11.66美元。
Hedge Funds Weigh In On Lilium
Several hedge funds and other institutional investors have recently bought and sold shares of LILM. Resources Investment Advisors LLC. acquired a new position in Lilium during the 2nd quarter worth approximately $26,000. Evoke Wealth LLC lifted its position in Lilium by 86.1% during the 1st quarter. Evoke Wealth LLC now owns 9,761 shares of the company's stock worth $39,000 after acquiring an additional 4,516 shares in the last quarter. Manchester Capital Management LLC acquired a new position in Lilium during the 1st quarter worth approximately $54,000. LPL Financial LLC acquired a new position in Lilium during the 2nd quarter worth approximately $64,000. Finally, UBS Group AG lifted its position in Lilium by 250.5% during the 1st quarter. UBS Group AG now owns 19,556 shares of the company's stock worth $78,000 after acquiring an additional 13,977 shares in the last quarter. 12.19% of the stock is owned by institutional investors and hedge funds.
幾家對衝基金和其他機構投資者最近買賣了LILM的股票。資源投資顧問公司。在第二季度收購了Lilium的一個新頭寸，價值約26,000美元。Evoke Wealth LLC在第一季度將其在Lilium的頭寸提高了86.1%。Evoke Wealth LLC在上個季度增持了4,516股後，現在持有9,761股該公司股票，價值39,000美元。曼徹斯特資本管理公司在第一季度收購了Lilium的一個新頭寸，價值約54,000美元。LPL Financial LLC在第二季度收購了Lilium的一個新頭寸，價值約6.4萬美元。最後，瑞銀集團在第一季度將其在Lilium的持倉提高了250.5%。瑞銀集團(UBS Group AG)在上個季度增持了13,977股瑞銀股票後，目前持有19,556股該公司股票，價值78,000美元。12.19%的股票由機構投資者和對衝基金持有。
Lilium Company Profile
Lilium N.V., a transportation company, engages in the research and development of electric vertical takeoff and landing aircrafts for use in high-speed air transport system for people and goods. Lilium N.V. was incorporated in 2015 and is headquartered in Wessling, Germany.
Lilium N.V.是一家運輸公司，從事人員和貨物高速航空運輸系統中使用的電動垂直起降飛機的研究和開發。Lilium N.V.成立於2015年，總部設在德國韋斯林。
Featured Articles
- Get a free copy of the StockNews.com research report on Lilium (LILM)
- No One Told These 3 Stocks It's a Down Week
- Is There a Cure for What is Ailing Teladoc Stock?
- Why Medical Products Maker Repligen May Be A Potential Buy
- At 10%, Is Arbor Realty Trust Dividend Worth It?
- Investors Should Tune Into RF Industries
- 免費獲取StockNews.com關於Lilium的研究報告(LILM)
- 沒有人告訴這三隻股票這是下跌的一週
- 有什麼辦法可以治癒Teladoc股票的問題嗎？
- 為什麼醫療產品製造商Repligen可能成為潛在收購對象
- 在10%的水平上，Arbor Realty Trust的股息值得嗎？
- 投資者應關注RF Industries
Receive News & Ratings for Lilium Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lilium and related companies with MarketBeat.com's FREE daily email newsletter.
接受《百合日報》的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Lilium和相關公司的最新新聞和分析師評級的每日簡要摘要。
